摘要:
La invención se refiere a vacunas terapéuticas para el tratamiento de neoplasias originadas por el virus del papiloma humano (VPH). En particular, las vacunas de la presente invención están formadas por cápsides pseudo- virales quiméricas de birnavirus conteniendo antígenos de papilomavirus.
摘要:
The invention relates to a method for obtaining transcriptionally active virus-like particles, i.e., particles comprising a genetic material of interest and the polymerase necessary for transcribing said gene in the target cell. The invention also relates to a method for obtaining recombinant virions comprising additional genomic segments and wherein said additional segments comprise the sequence of a gene of interest. Finally, the invention relates to the virus-like particles and to the recombinant virions obtained using the methods described in the present invention as well as to the use in medicine of said virus-like particles and said recombinant virions.
摘要:
La invención se refiere a vacunas profilácticas para la prevención de la gripe en humanos. En particular, las vacunas de la presente invención están formadas por cápsidas pseudo-virales quiméricas de birnavirus conteniendo el antígeno M2e del virus de la gripe.
摘要:
The invention relates to nanocarriers formed by protein assemblies, obtained by means of the assembly of a genetically modified self assembly protein in order to couple products of interest bound to a ligand. These protein nanocarriers can be used as a system for carrying and presenting products of interest.
摘要:
The empty capsids of the infectious bursal disease virus (IBDV), VLP(-VP4), are characterized in that they are constituted only by assembly of IBDV pVP2 proteins and IBDV VP3 proteins. Said capsids have immunogenic activity and can be used in the manufacture of vaccines for protecting animals from the infection caused by IBDV, as well as in the manufacture of gene therapy vectors.
摘要:
Provided herein are methods and compositions relating to Infectious Bursal Disease Virus (IBDV), and vaccines for treatment and prevention thereof.
摘要:
The invention relates to a composition and a method for manufacturing semi-dry or dry particles containing a mucoadhesive polymer and a bioactive agent such as, but not limited to, an Immunogenic Substance (e.g., a vaccine), that allows the oral or nasal administration and delivery of the bioactive agent essentially unaltered to mucosal surfaces in the animal, including an aquatic animal.
摘要:
The present invention relates to the display of antigenic or allergenic components along with a tissue-targeting component on viruses or virus-like particles. Capsid protein genes are recombinantly modified to contain the specified components, then expressed within a host organism, such as yeasts, bacteria, or algae, and allowed to spontaneously form active virus particles or virus-like particles. The recombinant complexes (virus or virus-like particle) can then be purified or used in situ as a therapeutic tool for disease or allergy prevention. The expression of multivalent and multifunctional components to increase the immunogenicity of the recombinant complexes, especially on oral administration, is provided.
摘要:
L'invention est relative ô des protéines chimériques obtenues par fusion de la polyprotéine d'un birnavirus avec un polypeptide hétérologue. L'invention concerne également des particules pseudovirales de birnavirus résultant de l'association desdites protéines chimériques, ainsi que l'utilisation desdites particules pour l'obtention de vaccins.